Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies
Open accessThe DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index; 20 of the 26 sources its claims cite were checked for support.
Abstract
Neurodevelopmental proteasomopathies are a group of disorders caused by variants in proteasome subunit genes, that disrupt protein homeostasis and brain development through poorly characterized mechanisms. Here, we report 26 distinct variants in PSMC5 , encoding the AAA⁺ ATPase subunit PSMC5/RPT6, in individuals with syndromic neurodevelopmental conditions. Combining genetic, multi-omics and biochemical approaches across cellular models and Drosophila , we unveil the essential role of proteasomes in sustaining key cellular processes. Loss of PSMC5/RPT6 function impairs proteasome activity, leading to protein aggregation, disruption of mitochondrial homeostasis, and dysregulation of lipid metabolism and immune signaling. It also compromises synaptic balance, neuritogenesis, and neural progenitor cell stemness, causing deficits in higher-order functions, including learning and locomotion. Pharmacological targeting of integrated stress response kinases reveals a mechanistic link between proteotoxic stress and spontaneous type I interferon activation. These findings expand our understanding of proteasome-dependent quality control in neurodevelopment and suggest potential therapeutic strategies for neurodevelopmental proteasomopathies.
Overview
CoChat Summary
TL;DR
This study identifies 26 distinct PSMC5 variants in 44 individuals with syndromic neurodevelopmental conditions and shows that loss of PSMC5/RPT6 function impairs proteasome activity, proteostasis, mitochondrial and lipid homeostasis, immune signaling, synaptic balance, and neural progenitor differentiation. Multi-model functional work links proteotoxic stress to type I interferon activation via the integrated stress response and suggests PKR, GCN2, and JAK inhibition as potential therapeutic targets.
Key findings
- In 44 affected individuals, 26 distinct PSMC5 variants were found, mostly missense (19/26) and within the AAA-ATPase domain (16/26); 33 cases were de novo, and ACMG/AMP simulation suggested pathogenicity for 25/26 variants. Recurrent variants included c.959C>G p.(Pro320Arg) in 6/44 and c.973C>T p.(Arg325Trp) in 9/44.
- Clinical features included global developmental delay in 42/44 (95%), speech absence/delay in 36/39 (92%), intellectual disability in 26/32 (81%), motor delay/impairment in 32/41 (78%), abnormal behavior in 30/39 (77%), seizures in 14/43 (33%), and abnormal facial shape in 32/40 (80%).
- Psmc5 knockdown in rat hippocampal neurons reduced PSMC5 protein to 12.71% ± 1.61% versus 100% ± 36.76% in controls, increased ubiquitin accumulation, and reduced vGlut⁺ excitatory puncta (control 1.2 ± 0.1 vs KD 0.8 ± 0.1; p = 0.0045) while vGat⁺ puncta remained stable. Drosophila Rpt6 knockdown impaired reversal learning (KD 1.5 ± 2 vs WT 43 ± 1.9; p < 0.0001) and caused age-dependent climbing decline.
- Patient T cells showed increased aggresome formation (MFI 64.53 ± 11.77 vs control 34.58 ± 2.148; p = 0.0159), high-molecular-weight ubiquitin accumulation, altered mitochondrial and lipid metabolism, and a type I IFN signature; PKR inhibitor C16, STING inhibitor H-151, GCN2 inhibitor A92, and JAK inhibitor baricitinib reduced IFN scores, whereas IRE1 inhibitor 4µ8C did not. iPSC-derived NPCs with p.(Arg325Trp) had 10% fewer SOX2⁺ and 7% fewer Nestin⁺ cells than wild-type.
Methods
- Genetic and clinical study of 44 affected individuals and available relatives, with genome/exome sequencing, clinical phenotyping, 3D structural mapping of variants, and GestaltMatcher facial analysis.
- Functional models included Drosophila Rpt6 knockdown for olfactory, reversal, and climbing assays; rat hippocampal neuron Psmc5 shRNA knockdown; mouse hippocampal neuron overexpression of selected PSMC5 variants; patient-derived T cells for proteomics, lipidomics, Native-PAGE, flow cytometry, and IFN assays; and CRISPR/Cas9-edited iPSCs differentiated into germ layers and neural progenitor cells.
- Analyses used t-tests, Mann-Whitney U tests, one-way ANOVA with Tukey or Dunnett’s post hoc tests, Wilcoxon tests, mass spectrometry, transcriptomics, and lipidomics, with statistical thresholds reported per experiment.
Limitations
- The paper states that no statistical method was used to predetermine sample size, no data were excluded except proteomics outliers with high missing values, experiments were not randomized, and investigators were not blinded to allocation during experiments and outcome assessment.
- The authors note limited follow-up on clinical progression, difficulty drawing a clear genotype-phenotype correlation because of important phenotypic variability, and in vivo/in vitro discrepancies for some variants.
- Evident from the text: functional assays often used small numbers of subjects, images, neurons, or biological replicates, and not all 26 variants were tested in every cellular or animal assay.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
12 Valid · 0 Not valid · 3 Not checked · 98 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As an ATPase, PSMC5 serves as a neuronal sensor that dynamically adjusts proteasome activity and localization to spines in response to protein turnover requirements through phosphorylation by CAMKIIα15,16.”
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Introduction
What the sources say
- Not checked — no full text of the sourcecites [15] Bingol, B. et al. Autophosphorylated CaMKIIalpha acts as a scaffold to recruit proteasomes to dendritic spines. Cell 140, 567–578 (2010). source
- Partly supportedcites [16] Jarome, T. J., Ferrara, N. C., Kwapis, J. L. & Helmstetter, F. J. CaMKII regulates proteasome phosphorylation and activity and promotes memory destabilization following retrieval. Neurobiol. Learn. Mem. 128, 103–109 (2016). sourceExperimental — accuracy not yet measured
Results §3.2 reports that CaMKII inhibition prevented retrieval-induced increases in proteasome activity and Rpt6 phosphorylation in the amygdala. The paper does not establish that PSMC5 acts as a neuronal sensor, adjusts activity according to protein-turnover requirements, or controls proteasome localization to spines; it also does not specify CaMKIIα as the kinase responsible in that experiment. Page numbers were not available in our copy. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Genetic investigations have further unveiled that loss-of-function variants in proteasome genes contribute to the onset and progression of a unique class of neurodevelopmental disorders (NDDs), specifically referred to as the neurodevelopmental proteasomopathies (NDPs)8 or proteasome associated neurodevelopmental disorders.”
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Introduction
What the sources say
- Partly supportedcites [8] Cuinat, S. et al. Understanding neurodevelopmental proteasomopathies as new rare disease entities: a review of current concepts, molecular biomarkers, and perspectives. Genes Dis. 11, 101130 (2024). sourceExperimental — accuracy not yet measured
The Neurodevelopmental proteasomopathies section describes an NDD caused by loss-of-function variants in PSMD12, supporting the claim that such variants can cause NDPs. The Molecular pathogenesis section says the mechanisms remain poorly understood and does not establish that the variants contribute to disease progression over time. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Nonetheless, facial analysis with GestaltMatcher17 suggested a recognizable facial gestalt among PSMC5 subjects.”
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Results > Subjects with PSMC5 variants present a similar facial gestalt
What the sources say
- Supportedcites [17] Hsieh, T. C. et al. GestaltMatcher facilitates rare disease matching using facial phenotype descriptors. Nat. Genet. 54, 349–357 (2022). source
The citation is attached to GestaltMatcher, identifying the facial-analysis method used by the citing authors. The source describes GestaltMatcher in the Abstract and explains in the Overview (page unavailable) that it uses facial descriptors and their distances to cluster patients and delineate phenotypes. The observation about PSMC5 subjects is the citing authors’ result, not a result attributed to this source. (LLM, conf=0.91)
hedgedstates an associationn = 15- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, Rpt6 KD caused significant defect in the ability to acquire novel association after initial training—a different behavior paradigm known as reversal learning (Tukey, p < 0.0001; N = 4; Fig. 3b), which is similar to what we previously reported in proteasome subunit gene PSMC3 KD models11.”
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Results > Psmc5 knockdown (KD) impairs fly reversal learning and alters proteostasis as well as excitatory/inhibitory balance of rat hippocampal neurons
What the sources say
- Supportedcites [11] Ebstein, F. et al. PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production. Sci. Transl. Med. 15, eabo3189 (2023). source
The cited paper’s section on silencing the PSMC3 Drosophila ortholog Rpt5 reports that flies learned the initial odor–shock association normally but performed significantly worse when the association was reversed (Fig. 2C). This supports the cited comparison to a PSMC3 knockdown model; the Rpt6 result and its statistics are the citing authors’ own findings, not attributed to this source. (LLM, conf=0.94)
plainstates a causen = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Cells harboring PSMC5 variants exhibit characteristics reminiscent of senescent or neurodegenerative cells, including impaired mitophagy47, type I IFN response48, abnormal apolipoproteins and/or cholesterol levels49,50, cognitive inflexibility51,52, impaired neuritogenesis53,54, and an imbalanced E/I ratio55,56.”
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Discussion
What the sources say
- Partly supportedcites [47] Chen, G., Kroemer, G. & Kepp, O. Mitophagy: an emerging role in aging and age-associated diseases. Front. Cell Dev. Biol. 8, 200 (2020). sourceExperimental — accuracy not yet measured
The BNIP3 and NIX-dependent mitophagy section reports impaired mitophagy in neurodegenerative disorders, supporting the comparison attached to citation 47. It does not address PSMC5 variants or establish that cells harboring them have impaired mitophagy. No page number is available in our copy. (LLM, conf=0.85)
- Supportedcites [48] Baruch, K. et al. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 346, 89–93 (2014). source
The cited paper supports the type I IFN response as an aging-associated characteristic: its Abstract reports an IFN-I-dependent expression profile in the choroid plexus of aged mice and humans. Citation 48 is attached to that characteristic, not to a claim that this paper studied PSMC5 variants. (LLM, conf=0.91)
- Supportedcites [49] Ma, C., Li, J., Bao, Z., Ruan, Q. & Yu, Z. Serum levels of ApoA1 and ApoA2 are associated with cognitive status in older men. Biomed. Res. Int. 2015, 481621 (2015). source
Citation 49 supports the apolipoprotein and cholesterol component of the comparison, not the other listed characteristics or the citing authors’ PSMC5-cell findings. In Results §3.2, the paper reports differences in ApoA2, ApoC2, and HDL-C across cognitive-status groups; the Discussion §4 also links ApoA1 and ApoA2 levels to cognitive impairment in older men. The evidence concerns serum levels in people, rather than measurements in cells. (LLM, conf=0.87)
- Supportedcites [50] de Chaves, E. P. & Narayanaswami, V. Apolipoprotein E and cholesterol in aging and disease in the brain. Future Lipido 3, 505–530 (2008). source
Citation 49/50 is attached to the apolipoprotein and cholesterol part of the sentence, not to the findings about PSMC5 variants. The sections “Cholesterol in normal aging,” “ApoE in normal aging,” and “Cholesterol & ApoE in AD” describe changes in these levels during aging and neurodegenerative disease. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
63 more claims
Create a free account to see all 113 claims and every source verdict.
- It may state two separate claims as one. 23
- Probably not a substantial claim. 25
- Not yet classified. 1
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Results > PSMC5 variants profoundly disrupt protein homeostasis and lipid metabolism, and activate mitophagy in T cells from NDD subjects
“Percentages of mitophagy-positive cells were significantly increased in patients (**p = 0.002, two-tailed Mann-Whitney U test).”
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Results > PSMC5 variants profoundly disrupt protein homeostasis and lipid metabolism, and activate mitophagy in T cells from NDD subjects
“controls (90.09 ± 3.330, n = 7) and patients (70.29 ± 3.525, n = 7)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Results > The recurrent PSMC5 heterozygous variant c.973C>T p.(Arg325Trp) perturbs the differentiation of induced pluripotent stem cells (iPSCs) into neural progenitor cells
“Fig. 9 PSMC5 variant c.973C>T p.(Arg325Trp) impairs iPSC differentiation into germ layers and neural progenitors.”
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Discussion
“the variant p.(Arg325Trp) does not impair the generation of the three germ layers (Fig. 9b)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Results > PSMC5 variants profoundly disrupt protein homeostasis and lipid metabolism, and activate mitophagy in T cells from NDD subjects
“T cells expanded from PBMCs of NDD subjects (S7, S14, S15, S25, S36; n = 5)”
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Results > PSMC5 variants profoundly disrupt protein homeostasis and lipid metabolism, and activate mitophagy in T cells from NDD subjects
“Left panel: representative histogram overlay comparing the six patient samples to a healthy control.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Methods > Proteomics of T cells (second set of analyses)
“Lysates/eluates from protein samples of 13 individuals”
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Methods > Proteomics of T cells (second set of analyses)
“(n = 11; 5 patients; 6 healthy controls)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Results > The recurrent PSMC5 heterozygous variant c.973C>T p.(Arg325Trp) perturbs the differentiation of induced pluripotent stem cells (iPSCs) into neural progenitor cells
“their three isogenic WT controls PSMC5(+/p.Arg325Trp)”
§ Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies > Results > The recurrent PSMC5 heterozygous variant c.973C>T p.(Arg325Trp) perturbs the differentiation of induced pluripotent stem cells (iPSCs) into neural progenitor cells
“Differentiation of PSMC5(+/+) and PSMC5(+/p.Arg325Trp) iPSCs into the three germ layers”
Citations
Cites
Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics
Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A., & Schwudke, D. (2008) · Journal of Lipid Research · doi:10.1194/jlr.d700041-jlr200 · Cited by 2,598
Rath, S., Sharma, R., Gupta, R., Ast, T., Chan, C., Durham, T. J., Goodman, R. P., Grabarek, Z., Haas, M. E., Hung, W. H. W., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1011 · Cited by 1,888 · cited 1×
“0 inventory 69 .”
The proteostasis network and its decline in ageing
Hipp, M. S., Kasturi, P., & Hartl, F. U. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0101-y · Cited by 1,642 · cited 2×
“Neuronal synaptic plasticity relies on continuous proteome renewal, necessitating robust translation at ribosomes and concurrent break-down of defective ribosomal products 2,4 .”
Classical conditioning and retention in normal and mutantDrosophila melanogaster
Tully, T., & Quinn, W. G. (1985) · Journal of Comparative Physiology A · doi:10.1007/bf01350033 · Cited by 1,183
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977 · cited 1×
“Effective protein clearance by the proteasome is crucial for various neuronal processes, including synaptic remodeling, cell migration, neurotransmitter release, long-term potentiation, long-term depression, and memory formation 5,6 .”
The proteasome: overview of structure and functions
TANAKA, K. (2009) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.85.12 · Cited by 862 · cited 1×
“2a and Supplementary Table 2) and underlines previous fi ndings in mice and plants 23,24 .”
Cognitive and behavioural flexibility: Neural mechanisms and clinical considerations
Uddin, L. Q. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00428-w · Cited by 698
Evidence for 28 genetic disorders discovered by combining healthcare and research data
Kaplanis, J., Samocha, K. E., Wiel, L., Zhang, Z., Arvai, K. J., Eberhardt, R. Y., Gallone, G., Lelieveld, S. H., Martin, H. C., McRae, J. F., et al. (2020) · Nature · doi:10.1038/s41586-020-2832-5 · Cited by 615 · cited 1×
“The pivotal role of PSMC5 in early human developmental processes had been strongly suggested by a signi fi cant enrichment of de novo variants in individuals with developmental disorders in a large international cohort study 22 .”
Self-citationAging-induced type I interferon response at the choroid plexus negatively affects brain function
Baruch, K., Deczkowska, A., David, E., Castellano, J. M., Miller, O., Kertser, A., Berkutzki, T., Barnett-Itzhaki, Z., Bezalel, D., Wyss-Coray, T., et al. (2014) · Science · doi:10.1126/science.1252945 · Cited by 615
Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction
Tai, H.-C., & Schuman, E. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2499 · Cited by 532 · cited 4×
“Effective protein clearance by the proteasome is crucial for various neuronal processes, including synaptic remodeling, cell migration, neurotransmitter release, long-term potentiation, long-term depression, and memory formation 5,6 .”
Influential
Cited by
Insights on suicidality and autism; and more
Adams, J. U. (2025) · The Transmitter · doi:10.53053/vvwt8912
Molecular mechanisms in rare proteasomopathies
Möller, S., Alvarez, F. L., Thiel, F. G., Wendlandt, M., & Krüger, E. (2026) · EULAR Rheumatology Open · doi:10.1016/j.ero.2025.12.005
Self-citationType I Interferonopathies: Fifteen Years On, From Concept to Therapeutic Perspectives
Ünal, D., Melki, I., & Frémond, M. (2026) · Current Rheumatology Reports · doi:10.1007/s11926-026-01228-w · Cited by 2
Metadata
- Authors
- Küry, S., Stanton, J. E., van Woerden, G. M., Bosc-Rosati, A., Hsieh, T.-C., Bray, L., Oloudé, M., Rosenfelt, C., Scott-Boyer, M. P., Most, V., Wang, T., Papendorf, J. J., de Konink, C., Deb, W., Vignard, V., Studencka-Turski, M., Besnard, T., Hajdukowicz, A. M., Thiel, F. G., Wolfgramm, S., Florenceau, L., Cuinat, S., Marsac, S., Verrès, Y., Dangoumau, A., Poirier, L., Wentzensen, I. M., Tuttle, A., Forster, C., Striesow, J., Golnik, R., Ortiz, D., Jenkins, L., Rosenfeld, J. A., Ziegler, A., Houdayer, C., Bonneau, D., Torti, E., Begtrup, A., Monaghan, K. G., Mullegama, S. V., Volker-Touw, C. M. L. N., van Gassen, K. L. I., Oegema, R., de Pagter, M. S., Steindl, K., Rauch, A., Ivanovski, I., McDonald, K., Boothe, E., Dauber, A., Baker, J., Fabie, N. A. V., Bernier, R. A., Turner, T. N., Srivastava, S., Dies, K. A., Swanson, L. C., Costin, C., Abdulrazak, A., Jobling, R. K., Pappas, J., Rabin, R., Niyazov, D., Chun-Hui Tsai, A., Kovak, K., Beck, D. B., Malicdan, M. C. V., Adams, D. R., Wolfe, L., Ganetzky, R. D., Muraresku, C. C., Babikyan, D., Sedláček, Z., Hančárová, M., Timberlake, A. T., Saif, H. A., Nestler, B., King, K., Hajianpour, M., Costain, G., Prendergast, D., Li, C., Geneviève, D., Vitobello, A., Sorlin, A., Philippe, C., Harel, T., Toker, O., Sabir, A., Lim, D., Hamilton, M. J., Bryson, L. J., Cleary, E., Weber, S., Hoffman, T. L., Cueto-González, A. M., Tizzano, E. F., Gómez-Andrés, D., Codina-Solà, M., Ververi, A., Pavlidou, E., Lambropoulos, A., Garganis, K., Rio, M., Levy, J., Langas, S. J., McRae, A. M., Lessard, M. K., D’Agostino, M. D., De Bie, I., Wegler, M., Abou Jamra, R., Kamphausen, S. B., Bothe, V., Potocki, L., Olinger, E., Sznajer, Y., Wiame, E., Thompson, M. L., Schroeder, M. C., Gooch, C., Smith, R. A., Pandya, A., Busch, L. M., Völker, U., Hammer, E., Wende, K., Cogné, B., Isidor, B., Meiler, J., Ripoll, C., Bigou, S., Laumonnier, F., Hildebrand, P. W., Eichler, E. E., McWalter, K., Krawitz, P. M., Roux-Dalvai, F., Elgersma, Y., Marcoux, J., Bousquet, M.-P., Droit, A., Poschmann, J., Grabrucker, A. M., Bolduc, F. V., Bézieau, S., Ebstein, F., & Krüger, E.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- University of Limerick (IE)
- Institut de Pharmacologie et de Biologie Structurale (FR)
- University of Bonn (DE)
- Inserm (FR)
- University of Alberta (CA)
- Leipzig University (DE)
- Peking University (CN)
- Universitätsmedizin Greifswald (DE)
- Centre Hospitalier Universitaire de Nantes (FR)
- Université de Tours (FR)
- Loyola University Chicago (US)
- Leibniz Institute for Plasma Science and Technology (DE)
- University of Pittsburgh (US)
- Baylor College of Medicine (US)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Centre Hospitalier Universitaire d'Angers (FR)
- Utrecht University (NL)
- University of Zurich (CH)
- University of Louisville (US)
- University of Mississippi Medical Center (US)
- Children's National (US)
- Children's Minnesota (US)
- University of Washington (US)
- Washington University in St. Louis (US)
- Boston Children's Hospital (US)
- Akron Children's Hospital (US)
- West Virginia University (US)
- Hospital for Sick Children (CA)
- NYU Langone Health (US)
- New York University (US)
- Duke University (US)
- Oregon Health & Science University (US)
- National Institutes of Health (US)
- Children's Hospital of Philadelphia (US)
- Center of Medical Genetics and Primary Health Care (AM)
- Charles University (CZ)
- Virginia Commonwealth University (US)
- Albany Medical College (US)
- University of Toronto (CA)
- McMaster University (CA)
- Hebrew University of Jerusalem (IL)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- Queen Elizabeth University Hospital (GB)
- Western General Hospital (GB)
- Sorbonne Université (FR)
- Kaiser Permanente (US)
- Vall d'Hebron Institut de Recerca (ES)
- Papageorgiou General Hospital (GR)
- University Hospital of Ioannina (GR)
- St. Luke's Hospital (GR)
- Hôpital Necker-Enfants Malades (FR)
- Northwestern University (US)
- Lurie Children's Hospital (US)
- McGill University Health Centre (CA)
- University Hospital Leipzig (DE)
- University Hospital Magdeburg (DE)
- Cliniques Universitaires Saint-Luc (BE)
- University of North Carolina at Chapel Hill (US)
- Vanderbilt University (US)
- Humboldt-Universität zu Berlin (DE)
- Howard Hughes Medical Institute (US)
- Erasmus MC (NL)
- Université Laval (CA)
- Corresponding author
- Küry, Sébastien
- Ebstein, Frédéric
- Krüger, Elke
- ORCID
- Küry, Sébastien
- Stanton, Janelle E.
- van Woerden, Geeske M.
- Bosc-Rosati, Amélie
- Hsieh, Tzung-Chien
- Bray, Lise
- Oloudé, Marielle
- Rosenfelt, Cory
- Most, Victoria
- Wang, Tianyun
- Deb, Wallid
- Vignard, Virginie
- Besnard, Thomas
- Thiel, Franziska G.
- Wolfgramm, Sophie
- Florenceau, Laëtitia
- Cuinat, Silvestre
- Verrès, Yann
- Dangoumau, Audrey
- Poirier, Léa
- Wentzensen, Ingrid M.
- Tuttle, Annabelle
- Striesow, Johanna
- Golnik, Richard
- Rosenfeld, Jill A.
- Ziegler, Alban
- Houdayer, Clara
- Bonneau, Dominique
- Torti, Erin
- Begtrup, Amber
- Monaghan, Kristin G.
- Mullegama, Sureni V.
- Oegema, Renske
- Steindl, Katharina
- Rauch, Anita
- Ivanovski, Ivan
- Boothe, Emily
- Dauber, Andrew
- Bernier, Raphael A.
- Turner, Tychele N.
- Srivastava, Siddharth
- Dies, Kira A.
- Abdulrazak, Alali
- Jobling, Rebekah K.
- Pappas, John
- Rabin, Rachel
- Niyazov, Dmitriy
- Beck, David B.
- Malicdan, May Christine V.
- Adams, David R.
- Wolfe, Lynne
- Ganetzky, Rebecca D.
- Muraresku, Colleen C.
- Babikyan, Davit
- Sedláček, Zdeněk
- Hančárová, Miroslava
- Timberlake, Andrew T.
- Hajianpour, MJ
- Costain, Gregory
- Li, Chumei
- Geneviève, David
- Vitobello, Antonio
- Sorlin, Arthur
- Philippe, Christophe
- Harel, Tamar
- Toker, Ori
- Sabir, Ataf
- Lim, Derek
- Hamilton, Mark J.
- Bryson, Lisa J.
- Cleary, Elaine
- Weber, Sacha
- Hoffman, Trevor L.
- Cueto-González, Anna M.
- Tizzano, Eduardo F.
- Gómez-Andrés, David
- Ververi, Athina
- Pavlidou, Efterpi
- Lambropoulos, Alexandros
- Garganis, Kyriakos
- Rio, Marlène
- Levy, Jonathan
- Langas, Sarah J.
- McRae, Anne M.
- Wegler, Meret
- Abou Jamra, Rami
- Kamphausen, Susanne B.
- Bothe, Viktoria
- Potocki, Lorraine
- Olinger, Eric
- Sznajer, Yves
- Thompson, Michelle L.
- Schroeder, Molly C.
- Gooch, Catherine
- Pandya, Arti
- Busch, Larissa M.
- Völker, Uwe
- Hammer, Elke
- Wende, Kristian
- Cogné, Benjamin
- Isidor, Bertrand
- Meiler, Jens
- Bigou, Stéphanie
- Laumonnier, Frédéric
- Hildebrand, Peter W.
- Eichler, Evan E.
- McWalter, Kirsty
- Krawitz, Peter M.
- Roux-Dalvai, Florence
- Elgersma, Ype
- Marcoux, Julien
- Bousquet, Marie-Pierre
- Droit, Arnaud
- Poschmann, Jeremie
- Grabrucker, Andreas M.
- Bézieau, Stéphane
- Ebstein, Frédéric
- Krüger, Elke
- Venue
- Nature Communications
- Published
- 2025-11-26
- Volume
- 16
- Issue
- 1
- Pages
- 10545-10545
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC12658096
- OpenAlex
- W4416719051
- Cited by
- 3
- References
- 70
- Citations by year
- 2026: 2 · 2025: 1
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (acceptedVersion, other-oa)
- HAL (submittedVersion, cc-by)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- U.S. Department of Health and Human Services (R01MH101221, K23NS119666)
- European Commission (ANR-10-IAIHU-06, HICF-1009-003, HORIZON2020, 825575)
- European Cooperation in Science and Technology (ProteoCure CA20113)
- Deutsche Forschungsgemeinschaft (SPP2453, 825575, 3HP-HP-FPA ERN-01-2016/739516, CA20113, SPP 2453 KR1915/11-1, RTG PRO 2719)
- Agence Nationale de la Recherche (ANR-10-IAIHU06, 10-IAIHU-06, ANR-21-CE17-0005, ANR-10, ANR-22-RAR4-0001)
- Institut National de la Santé et de la Recherche Médicale (ANR-10-IAIHU-06)
- National Natural Science Foundation of China (82201314)
- AXA Research Fund
- Bundesministerium für Bildung und Forschung (03Z22DN12)
- Centre Hospitalier Universitaire de Nantes (PROG/09/72-03, RC22_0020)
- National Institutes of Health (-0001, ANR-10-IAIHU-06)
- Fundamental Research Funds for the Central Universities (BMU2022RCZX038)
- National Institute of Mental Health (R01MH101221, R01MH126933)
- National Institute of Neurological Disorders and Stroke (K23NS119666)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- Rpt6, proteasome, AAA+ ATPase, proteostasis, protein aggregation, mitochondrial homeostasis, lipid metabolism, immune signaling, synaptic function, neurite outgrowth, integrated stress response, type I interferon, proteotoxic stress, Drosophila model
- MeSH terms
- ATPases Associated with Diverse Cellular Activities, Adenosine Triphosphatases, Animals, Child, Drosophila melanogaster, Female, Humans, Male, Mitochondria, Neurons, Drosophila Proteins, Proteasome Endopeptidase Complex, Neurodevelopmental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies. https://app.cochat.ai/papers/10.1038/s41467-025-65556-8
- The paper
- Küry, S., Stanton, J. E., van Woerden, G. M., Bosc-Rosati, A., Hsieh, T.-C., Bray, L., Oloudé, M., Rosenfelt, C., Scott-Boyer, M. P., Most, V., Wang, T., Papendorf, J. J., de Konink, C., Deb, W., Vignard, V., Studencka-Turski, M., Besnard, T., Hajdukowicz, A. M., Thiel, F. G., . . . Krüger, E. (2025). Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies. Nature Communications. https://doi.org/10.1038/s41467-025-65556-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.